Product Images Irinotecan Hydrochloride

Irinotecan is a cytotoxic agent used for intravenous use only after dilution, in the treatment of colorectal cancer. It comes in a single-dose vial of sterile, aqueous solution with a strength of 100mg/5ml (20mg/ml) and is available in NDC code 59923-715-05. The package should be discarded if damaged or leaking, and the unused portion should not be used. It also contains sorbitol powder, water for injection, and lactate acid. The dosage and usage information are available in the accompanying prescribing information. It is produced in India and distributed by Areva Pharmaceuticals, Inc.*

This appears to be the description of a medication called "Irinotecan Hydrochloride" that comes in injection form. The text includes its NDC (5982371505), USP (United States Pharmacopeia) designation, and dosage (20mg/mL). The medication is stored in an aqueous solution with sodium hydroxide and is only for intravenous use. The dosage and use instructions are not provided in this text, and it is recommended to refer to the accompanying prescribing information. The medication is distributed by a company called "Sagent Pharmaceuticals" in Georgetown, Indiana.*

Irinotecan Hydrochloride Injection is a cytotoxic agent that comes in a 15 mL single-dose vial containing 300mg irinotecan hydrochloride, USP (20 mg/mL) for intravenous use only. It is a sterile, aqueous solution that must be diluted before use. Each millilitre of the solution includes irinotecan hydrochloride, USP (as trihydrate), sorbitol powder, lactic acid, and water for injection. It must be stored at 20°C to 25°C and protected from freezing and light. The solution is produced by Areva Pharmaceuticals, Inc. in India, and the product information should be reviewed.*

This is a description of a medication called Irinotecan Hydrochloride Injection, which is a cytotoxic agent used only for intravenous use by dilution. It comes in a single-dose 2mL vial and should be discarded if any unused portion remains. The medication is stored in a carton until it is ready to be used and must be protected from light and freezing. The provided text also includes information on the dosages and usage of the medication. It is distributed by Areva Pharmaceutica, Inc. in Georgetown, Indiana.*

This is a description of a medication called Irinotecan Hydrochloride which is an injection used for intravenous use only. The medication contains 20mg of irinotecan hydrochloride, sorbitol powder, lactic acid and water. The pH may be adjusted if necessary. The medication is a cytotoxic agent and is to be protected from light and freezing. It is distributed by Areva Pharmaceuticals Inc. and comes in a 2mL single-dose vial with the code TSIDRIGS 2011. Detailed information on dosage and use is provided with the drug.*

The text contains a graph entitled "Figure 2 Survival" with measurements represented by decimal numbers from 0 to 10 and months labeled at the bottom. The text also includes the words "notecansFULY" and "Probabllity," but no additional context is provided.*